Convivia: Phase IIa started

Raptor's Bennu Pharmaceuticals Inc. subsidiary began a double-blind, placebo-controlled, dose-escalation, U.S. Phase IIa trial of oral Convivia in up to 32 patients of Japanese descent. ...